AON:NYSEAon plc Analysis
Data as of 2026-05-23 - not real-time
$324.78
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Aon plc trades at $324.78, comfortably above its 20‑day SMA of $317.38 and 50‑day SMA of $321.59, yet still below the 200‑day SMA of $341.88, signaling a short‑term upside potential within a longer‑term bearish backdrop. The MACD histogram is positive (+1.52) and the line sits above the signal, reinforcing bullish momentum, while the RSI at 54.8 suggests the stock is neither overbought nor oversold.
Volatility is elevated at 25% over the past 30 days and beta is modest (~0.71), indicating market‑wide swings but limited systematic risk. Fundamentals remain strong: revenue grew 6.5% YoY, ROE is an impressive 46%, operating margin stands at 35.8% and free cash flow exceeds $3.3 bn, supporting a sustainable dividend yield of 1% with a low 16% payout ratio. However, the current price is well above the DCF‑derived fair value of $202 and its PE of 17.8 exceeds the industry average of 16.8, suggesting the stock is overvalued despite the positive earnings outlook. Recent material news – the launch of the Aon Digital Placement Exchange (DPX) and an analyst upgrade to a $388 target – adds upside catalysts, but the overall valuation gap tempers enthusiasm.
Volatility is elevated at 25% over the past 30 days and beta is modest (~0.71), indicating market‑wide swings but limited systematic risk. Fundamentals remain strong: revenue grew 6.5% YoY, ROE is an impressive 46%, operating margin stands at 35.8% and free cash flow exceeds $3.3 bn, supporting a sustainable dividend yield of 1% with a low 16% payout ratio. However, the current price is well above the DCF‑derived fair value of $202 and its PE of 17.8 exceeds the industry average of 16.8, suggesting the stock is overvalued despite the positive earnings outlook. Recent material news – the launch of the Aon Digital Placement Exchange (DPX) and an analyst upgrade to a $388 target – adds upside catalysts, but the overall valuation gap tempers enthusiasm.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price above short‑term SMAs but below long‑term SMA
- Bullish MACD histogram with neutral RSI
- Support at $306.5 and resistance at $330.2
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Strong revenue growth and high ROE
- Robust cash flow supporting dividend sustainability
- Analyst target price uplift and new DPX platform launch
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- Overvaluation relative to DCF fair value
- Consistent profitability and low payout ratio
- Diversified global footprint mitigating geographic risk
Key Metrics & Analysis
Financial Health
Revenue Growth6.50%
Profit Margin22.54%
P/E Ratio17.8
ROE46.45%
ROA6.05%
Debt/Equity155.05
P/B Ratio7.1
Op. Cash Flow$3.8B
Free Cash Flow$3.3B
Industry P/E16.8
Technical Analysis
TrendBearish
RSI54.8
Support$306.52
Resistance$330.22
MA 20$317.38
MA 50$321.59
MA 200$341.88
MACDBullish
VolumeStable
Fear & Greed Index91.61
Valuation
Fair Value$202.05
Target Price$384.84
Upside/Downside18.49%
GradeOvervalued
TypeGrowth
Dividend Yield1.01%
Risk Assessment
Beta0.04
Volatility25.17%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.